Topamax Drug: FDA warned that Topiramate could cause Birth Defects

Elevated risk for cleft lip and cleft palate in babies born to women who took topiramate during pregnancy

FDA Warns That Topiramate Could Cause Birth Defects: What to Tell Patients
Elevated risk for cleft lip and cleft palate in babies born to women who took topiramate during pregnancy

The FDA has issued several warnings about the use of topiramate by childbearing woman based on data from two registries, which showed an increased risk of oral clefts in infants exposed to monotherapy during the first trimester of pregnancy.

The FDA said topiramate would now be classified as a “Pregnancy Category D” drug, meaning there is evidence of human fetal risk based on human data.

Read FDA Warns That Topiramate Could Cause Birth Defects: What to Tell Patients
Neurology Today: 07 April 2011 – Volume 11 – Issue 7 – pp 1,8-9

FDA Safety Information for Patients and Providers:
Topiramate (marketed as Topamax) Information, 03 April 2011

Author: DES Daughter

Activist, blogger and social media addict committed to shedding light on a global health scandal and dedicated to raise DES awareness.

4 thoughts on “Topamax Drug: FDA warned that Topiramate could cause Birth Defects”

Leave a Reply to DES Daughter Cancel reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.